SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001789769-24-000064
Filing Date
2024-06-13
Accepted
2024-06-13 17:01:18
Documents
1
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718312468.html 4  
1 FORM 4 wk-form4_1718312468.xml 4 4307
  Complete submission text file 0001789769-24-000064.txt   5771
Mailing Address C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address
Gibson Neil W (Reporting) CIK: 0001555918 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40215 | Film No.: 241042041

Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Issuer) CIK: 0001789769 (see all company filings)

IRS No.: 832072195 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)